Location History:
- Asturias, ES (2015)
- Austrias, ES (2018)
Company Filing History:
Years Active: 2015-2018
Title: Innovations in Antimicrobial Agents by Lorena Rodriguez Rubio
Introduction
Lorena Rodriguez Rubio is an accomplished inventor based in Austrias, Spain. She has made significant contributions to the field of antimicrobial agents, particularly through her innovative research on peptidoglycan hydrolases. With a total of two patents to her name, her work has the potential to revolutionize the treatment of bacterial infections.
Latest Patents
Lorena's latest patents focus on virion-associated peptidoglycan hydrolases, which have shown promise as antimicrobial agents due to their ability to lyse Gram-positive bacteria upon contact. One of her notable inventions involves fusion proteins, such as HydH5SH3b and HydH5Lyso, which combine the full-length peptidoglycan hydrolase HydH5 from the bacteriophage vB_SauS-phi-IPLA88 with the SH3b cell wall-binding domain from lysostaphin. These proteins exhibited high lytic activity against live cells, including methicillin-resistant Staphylococcus aureus (MRSA) strains. Another patent highlights the efficacy of HydH5 and its derivatives in combination with the endolysin LysH5, suggesting a synergistic effect that enhances their antimicrobial properties.
Career Highlights
Lorena Rodriguez Rubio works for the United States of America, as represented by the Secretary of Agriculture. Her research has garnered attention for its innovative approach to combating bacterial infections, particularly those caused by resistant strains. Her work is characterized by a commitment to advancing the field of microbiology and developing effective treatments.
Collaborations
Some of her notable coworkers include David M Donovan and Beatriz Martinez Fernandez. Their collaborative efforts have contributed to the success of her research and the development of her patented technologies.
Conclusion
Lorena Rodriguez Rubio's contributions to the field of antimicrobial agents through her innovative patents demonstrate her dedication to addressing critical health challenges. Her work has the potential to significantly impact the treatment of bacterial infections, particularly in the face of rising antibiotic resistance.